Stated preferences research in health care applications to increase patient-centeredness in the clinical and policy contexts

18 October 2017
Calgary, Alberta

The NOAHE Health Economics and Technology Assessment Rounds are presented by the Institute of Health Economics, the University of Calgary Health Economics Group and HTA Unit, and the University of Alberta Health Economics Unit. Their aim is to advance health economics research and influence health policy, to improve the health outcomes of Canadians.

Stated preferences: research in health care applications to increase patient-centeredness in the clinical and policy contexts

At the request of the speaker, the video for this session will not be made available. If you have any questions, please contact us at NOAHE@ihe.ca

Presenter

Deborah Marshall profile picture Dr. Deborah Marshall holds a Canada Research Chair, Health Services and Systems Research as a Professor at the University of Calgary and Arthur J.E. Child Chair of Rheumatology Outcomes Research in the McCaig Institute of Bone and Joint Health. She is the Director of Health Technology Assessment at the Alberta Bone and Joint Health Institute, a Senior Scientist at Arthritis Research Canada, and a member of the O’Brien Institute of Public Health.

Dr. Marshall has experience in technology assessment agencies, academia and pharmaceutical and diagnostics industry research settings in Canada, the United States, and Europe. Her research program focuses on patient preferences and patient engagement research, cost-effectiveness analysis, and dynamic simulation modelling of health services delivery to improve the effectiveness and efficiency of health care services. Dr. Marshall is an active member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) as the Past President of the Board of Directors and various Task Forces. She serves as a member Board of Directors for Health Technology Assessment International (HTAi), the co-chair of the Scientific Research Committee and Board of Directors of the Arthritis Alliance of Canada (AAC), and a member of the Scientific Advisory Committee of the Alberta PROMs & EQ-5D Research & Support Unit (APERSU).